Categories: News

National Lipid Association and Paradigm Medical Communications, LLC Announce Collaborative Partnership in Lipids Education

JACKSONVILLE, Fla. and ORANGEBURG, N.Y., March 02, 2021 (GLOBE NEWSWIRE) — The National Lipid Association (NLA), the preeminent global authority on lipid disorders, and Paradigm Medical Communications, LLC (Paradigm), a multiple award-winning medical education company, are proud to announce their collaborative partnership to design and implement How Low Do You Go? Novel Strategies to Address LDL-C Limbo, an 18-month blended learning, certified continuing education curriculum for clinicians, comprising live and online activities, to launch in May 2021.

“The NLA is an organization dedicated to the prevention of atherosclerotic cardiovascular disease (ASCVD) and its comorbidities via risk factor management. Cardiovascular disease risk reduction with a focus on lipids and low-density lipoprotein lowering is one of the NLA’s main missions/goals. This educational collaboration with Paradigm will enable the NLA to continue to achieve this important goal,” said Joseph J. Saseen, PharmD, CLS, FNLA, President of the NLA.

“The NLA and Paradigm recognize the value and importance of collaborative educational initiatives to expand and enhance the practice of lipid management in clinical medicine. Working together, the NLA and Paradigm will design and implement this strategic and impactful curriculum, combining their significant clinical and instructional design skills to great effect,” said Will Riley, Managing Partner, and Scott Scire, Vice President of Collaborative Partnerships, of Paradigm.

This initiative is made possible by an educational grant from the Novartis Office of Grants and Education.

ABOUT THE NATIONAL LIPID ASSOCIATION

The NLA is a multidisciplinary specialty society focused on prevention of cardiovascular disease and other lipid-related disorders. The NLA’s mission is to enhance the practice of lipid management in clinical medicine, and one of its goals is to enhance efforts to reduce death and disability related to disorders of lipid metabolism in patients. Members include physicians (MDs and DOs) and other healthcare professionals from an array of disciplines including PhDs, researchers, nurses, nurse practitioners, physician assistants, pharmacists, exercise physiologists, and dietitians. The NLA has achieved reaccreditation status from Joint Accreditation for Interprofessional Continuing Education for a new 6-year term through November 2026. This recent reaccreditation enables the NLA to continue development of medical education for the entire healthcare team and maintain its reputation for delivering the highest quality education to its membership and beyond.

To stay up to date on the NLA and its activities, visit www.lipid.org or follow us on Twitter (@nationallipid), Facebook (https://www.facebook.com/nationallipid/), and Instagram (https://www.instagram.com/nationallipid/).

ABOUT PARADIGM MEDICAL COMMUNICATIONS, LLC

Paradigm is a multiple award-winning medical education company that develops innovative activities, expertly designs certified educational initiatives to fulfill the needs of diverse, sophisticated clinical audiences, and diligently monitors ongoing activities to facilitate continuous growth and improvement. Paradigm’s mission is to provide educational initiatives designed to bridge identified professional practice gaps of physicians and other healthcare providers. Paradigm is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

For additional information about Paradigm, please visit our website at www.paradigmmc.com.

CONTACT: CONTACT:
Lindsay Hart
Director, Marketing and Communications
904.998.0853
lhart@lipid.org

Staff

Recent Posts

Daily Fit Notes Rolls Out Affordable Fitness Solutions for the Modern Lifestyle

Daily Fit Notes, founded by Justin Brey in New York, launches a text-based subscription fitness…

1 day ago

WillowWood Rebrand by DD.NYC Wins Gold Anthem Award for Product and Innovation in 2024 Rebrand

MT. STERLING, Ohio, Dec. 20, 2024 /PRNewswire/ -- WillowWood, a global leader in prosthetic solutions,…

1 day ago

Quantum Biopharma Announces Closing of Second Tranche

TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"…

2 days ago

Glow Lifetech Announces Completion of Final Payment under Swiss Pharma Share Exchange Agreement and Debt Settlement

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…

2 days ago

Bloom Burton & Co. Inc. Announces Changes to Holdings in Satellos Bioscience Inc.

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Bloom Burton & Co. Inc. (Bloom Burton)…

2 days ago